लोड हो रहा है...

Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?

BACKGROUND: Both dose-escalated external beam radiotherapy (DE-EBRT) and androgen deprivation therapy (ADT) improve the outcomes in patients with intermediate-risk prostate cancer. Despite this, there are only few reports evaluating DE-EBRT for patients with intermediate-risk prostate cancer receivi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Onco Targets Ther
मुख्य लेखकों: Shakespeare, Thomas P, Wilcox, Shea W, Aherne, Noel J
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2016
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4806761/
https://ncbi.nlm.nih.gov/pubmed/27073327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S102327
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!